Description:
Patients with primary intermediate risk prostate cancer for whom radical prostatectomy is indicated, will be invited to participate to the present study. Positron Emission Tomography coupled with scanner (PET-CT) using a radiotracer : 68Ga-RM2 and Positron Emission Tomography coupled with scanner (PET-CT) using another radiotracer : 68Ga-PSMA-617, will be scheduled.
Sponsor:
University Hospital, Bordeaux
Contacts:
Henri CLERMONT-GALLERANDE (Principal Investigator)henri.de-clermont-galleran@chu-bordeaux.fr
05 56 79 55 40
Clément MORGATclement.morgat@chu-bordeaux.fr
05 56 79 55 40
Government Study Link:
NCT03606837 - Click here to see study onClinicalTrials.gov